Phase I study of the novel anticancer drug PM00104 as a 24-hour IV infusion every 3 weeks (q3w) in patients (pts) with advanced solid tumors or lymphoma This is an ASCO Meeting Abstract from the 2009 ...
Epoetin beta in the treatment of anemia in patients with advanced gastrointestinal cancer. Patients (n = 236) with progressive, measurable disease were randomized to three groups and received FU 2,600 ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results